http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201991551-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6415
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64
filingDate 2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201991551-A1
titleOfInvention PEPTIDE LIGANDS FOR BINDING WITH MT1-MMP
abstract A peptide ligand specific for MT1-MMP comprising a polypeptide comprising two diaminopropionic acid (Dap) or N-alkyldiaminopropionic acid (N-AlkDap) residues and a third residue selected from cysteine, Dap or N-AlkDap, separated by at least , sequences of two loops, and a molecular framework, wherein the peptide is bound to the framework by covalent alkylamino bonds with Dap or N-AlkDap residues of the polypeptide and covalent thioether bonds with cysteine, when the third residue is cysteine, thus polypeptide loops are formed on the molecular framework, where the peptide ligand comprises the amino acid sequence of formula (II) or a pharmaceutically acceptable salt thereof; where A, A, and An are independently cysteine, L-2,3-diaminopropionic acid (Dap), N-beta-alkyl-L-2,3-diaminopropionic acid (N-AlkDap), or N-beta-haloalkyl-L -2,3-diaminopropionic acid (N-HAlkDap), provided that at least one of A, A, and A is Dap, N-AlkDap, or N-HAlkDap; X represents any amino acid residue; U is a polar uncharged amino acid residue selected from N, C, Q, M, S, and T; and O is a non-polar aliphatic amino acid residue selected from G, A, I, L, P and V.
priorityDate 2017-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25201556
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46906042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485715
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID742887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566024

Total number of triples: 24.